Former Chief Financial and Business Officer · Whitehawk Therapeutics, Inc. (WHWK)

Michael Rogers

A named executive officer of Whitehawk Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,587,740

Salary $317,178Stock awards $0

FY2018: $890,663

2nd of 5 named executive officers at Whitehawk Therapeutics by FY2019 total.

5 named officers on file for Whitehawk Therapeutics, FY2019

Michael Rogers’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Whitehawk Therapeutics’s whole pay program stands against its peers

  • Whitehawk Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on WHWK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2020 (DEF 14A).

Free

Get Michael Rogers’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Rogers compensation by year

Whitehawk Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Whitehawk Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$48,296$375,000$317,178
Bonus$0$0$0
Stock awards$0$0$0
Option awards$1,000,446$319,966$800,036
Non-equity incentive$21,250$195,000$0
Pension and deferred compensation$0$0$0
All other$47$697$470,526
Total$1,070,039$890,663$1,587,740

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Whitehawk Therapeutics, Inc. DEF 14A filed April 27, 2020, accession 0001564590-20-018861, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Whitehawk Therapeutics, Inc. filed document, accession 0001564590-20-018861. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2020.

$1.1M
$891K
$1.6M
FY17
FY18
FY19
SalaryNon-equity incentiveOption awardsAll other

Whitehawk Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Stephen HoffmanFormer Chief Executive Officer$2,088,701
Michael Rogers · this pageFormer Chief Financial and Business Officer$1,587,740
Joseph GardnerPresident and Founder, Principal Executive Officer$1,130,992
Kevin PetersChief Medical and Scientific Officer$948,069
Regina MarekVP Finance, Principal Financial and Accounting Officer$485,590

The full Whitehawk Therapeutics compensation record

free company brief

This page is one person within Whitehawk Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Whitehawk Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Rogers's compensation dossier · One-time report. No refunds.